GO
Loading...

Express Scripts Holding Co

More

  • HALFTIME REPORT FINAL TRADES Tuesday, 23 Dec 2014 | 1:00 PM ET

    Halftime Report traders give their final trades for the day.

  • NEW YORK, Dec 23- U.S. stock index futures were little changed on Tuesday, after the Dow and S&P 500 closed at fresh records and ahead of a raft of economic data. *Major Wall Street indexes have risen for four straight sessions, pushing the benchmark S&P index to its 50th record high of the year. The S&P has risen 5.4 percent over that period, its best 4- day run since July...

  • LOS ANGELES, Dec 23- Express Scripts, the largest manager of prescription drug plans for U.S. employers, is taking an increasingly aggressive stance in price negotiations with pharmaceutical companies after winning discounts on medications with a strategy introduced last year. On Monday, Express Scripts said it lined up a cheaper price for AbbVie Inc's newly...

  • *Gilead falls as Express Scripts picks AbbVie treatment. *Dow boosted by gains at Intel, IBM; Dow, S&P end at record. Intel Corp rose 2.3 percent to $37.21, providing the biggest boost to the Dow, while IBM rose 1.8 percent to $161.44 and Cisco Systems rose 1.6 percent to $28.22.

  • *Gilead falls as Express Scripts picks AbbVie treatment. *Dow boosted by gains at Intel, IBM; S&P ends at record. Intel Corp rose 2.3 percent to $37.21, providing the biggest boost to the Dow, while IBM rose 1.8 percent to $161.44 and Cisco Systems rose 1.6 percent to $28.22.

  • *Gilead falls as Express Scripts picks AbbVie treatment. *Dow boosted by gains at Intel, IBM. The S&P energy index fell 1.2 percent as the day's weakest sector; Chevron Corp lost 1 percent to $111.76 while Halliburton Co was off 2.2 percent at $39.61.

  • Dec 22- The largest U.S. pharmacy benefit manager said on Monday it has lined up a cheaper price for AbbVie Inc's newly approved hepatitis C treatment and, in most cases, will no longer cover Gilead Sciences Inc's treatments after trying for nearly a year to win a deeper discount. Express Scripts' move reignited investor concerns that pharmaceutical companies...

  • *Gilead falls as Express Scripts picks AbbVie treatment. *Dow boosted by gains at Intel, IBM. The S&P energy index fell 1.6 percent as the day's weakest sector; Chevron Corp lost 1.3 percent to $111.44 while Halliburton Co was off 1.9 percent at $39.70.

  • Gilead falls as Express Scripts picks AbbVie treatment. Express Scripts, the nation's largest pharmacy benefit manager, said it would no longer cover Gilead's treatments after it lined up a cheaper price from AbbVie Inc for its newly approved hepatitis C treatment. "That is very specific to Gilead, so that one is getting crushed, but it shouldn't necessarily set...

  • Dec 22- The nation's largest pharmacy benefit manager has lined up a cheaper price from AbbVie Inc on its newly approved hepatitis C treatment and, in most cases, will no longer cover Gilead Sciences Inc treatments, Express Scripts said on Monday. Express Scripts has opposed the $84,000 pricetag of Gilead Sciences' Sovaldi treatment since it was approved a year...

  • *Gilead falls as Express Scripts picks AbbVie treatment. NEW YORK, Dec 22- U.S. stocks were modestly higher on Monday, after the benchmark S&P 500 notched its best weekly performance in nearly two months, as a sharp drop in Gilead Sciences reined in broader gains. Express Scripts, the nation's largest pharmacy benefit manager, has lined up a cheaper price from AbbVie...

  • AbbVie gets exclusive hepatitis C billing Monday, 22 Dec 2014 | 9:28 AM ET

    Express Scripts says its largest plan will cover only AbbVie's hepatitis C regimen, excluding drugs from Gilead and J&J.

  • Early Movers: AMC, American Apparel, Staples & more Monday, 22 Dec 2014 | 9:08 AM ET

    Companies making headlines before the bell Monday.

  • *Gilead falls as Express Scripts picks AbbVie treatment. Brent last traded down 26 cents at $61.12 while U.S. crude was last off 0.6 percent at $56.77 after Saudi Arabia indicated it could increase its output. "Oil is in the process of bottoming out here," said Peter Cardillo, chief market economist at Rockwell Global Capital in New York.

  • *Gilead falls as Express Scripts chooses AbbVie treatment. NEW YORK, Dec 22- U.S. stock index futures advanced on Monday, after the S&P 500 notched its best weekly performance in almost two months, ahead of data on the housing market. Brent last traded down 21 cents at $61.17 while U.S. crude was last off 0.7 percent at $56.74 after Saudi Arabia indicated it could...

  • US STOCKS-Futures climb after three-day run Monday, 22 Dec 2014 | 7:45 AM ET

    *Gilead falls as Express Scripts chooses AbbVie treatment. NEW YORK, Dec 22- U.S. stock index futures advanced on Monday, after the S&P 500 notched its best weekly performance in almost two months, as oil prices continued to show signs of stabilizing. However, Brent pulled back to last trade down 14 cents to $61.24 while U.S. crude was last off 0.4 percent at $56.91.

  • After-hours buzz: Coca-Cola, Verifone & more Monday, 15 Dec 2014 | 5:46 PM ET

    Check out which companies are making headlines after the bell Monday: Coca-Cola, Verifone & more

  • Self-critical, Cramer reveals big stock regret Thursday, 20 Nov 2014 | 4:59 PM ET
    A woman on an escalator in a Walgreens store in New York.

    Looking back at his investment decisions over the past five years, Cramer wants to kick himself for doing this.

  • Early Movers: HSY, FB, GRMN, WLP, EA, DAL & more Wednesday, 29 Oct 2014 | 8:16 AM ET
    A trader works on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • After-hours buzz: Express Scripts, Facebook & more Tuesday, 28 Oct 2014 | 5:00 PM ET

    Check out which companies are making headlines after the bell Tuesday: Express Scripts, Facebook & more.